PFM Health Sciences, LP

Q4 2013 13F Holdings Report, Restatement, Stock Holdings

Signature - Title
Darren Mooney - Chief Compliance Officer
Location
San Francisco, CA
Holdings as of
December 31, 2013
Value $
$4.97B
Num holdings
60
Date filed
2/21/2014, 04:05 PM
Description
All US holdings of this investor are reported in this report. The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as of the end of the calendar quarter for which the report is filed, and the total market value. The market value column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in accounts.
Previous filing
Q3 2013 - Feb 21, 2014
Options Holdings
Showing stock holdings, see here for options holdings
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2013 Q4 - Restatement compared to 2013 Q3 - Restatement by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Darin Sadow Chief Compliance Officer San Francisco, California 2/21/2014

This amendment is being filed to correct the amounts reported in Columns 5 and 8 of the Information Table with respect to certain option positions. The amounts previously reported reflected the number option contracts instead of the number of shares underlying such contracts.